These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31897243)

  • 1. Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1.
    Zhang X; Liu P; Shang Y; Kerndl H; Kumstel S; Gong P; Vollmar B; Zechner D
    J Cancer; 2020; 11(2):479-487. PubMed ID: 31897243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer.
    Zhang X; Kumstel S; Jiang K; Meng S; Gong P; Vollmar B; Zechner D
    J Adv Res; 2019 Nov; 20():9-21. PubMed ID: 31193017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malate dehydrogenase-2 inhibitor LW6 promotes metabolic adaptations and reduces proliferation and apoptosis in activated human T-cells.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    Exp Ther Med; 2015 Nov; 10(5):1959-1966. PubMed ID: 26640580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells.
    Sato M; Hirose K; Kashiwakura I; Aoki M; Kawaguchi H; Hatayama Y; Akimoto H; Narita Y; Takai Y
    Mol Med Rep; 2015 Sep; 12(3):3462-3468. PubMed ID: 26017562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells.
    Wendt EHU; Schoenrogge M; Vollmar B; Zechner D
    Anticancer Res; 2020 Jan; 40(1):153-160. PubMed ID: 31892563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line.
    Lee K; Kang JE; Park SK; Jin Y; Chung KS; Kim HM; Lee K; Kang MR; Lee MK; Song KB; Yang EG; Lee JJ; Won M
    Biochem Pharmacol; 2010 Oct; 80(7):982-9. PubMed ID: 20599784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-cyano-4-hydroxycinnamate impairs pancreatic cancer cells by stimulating the p38 signaling pathway.
    Schönrogge M; Kerndl H; Zhang X; Kumstel S; Vollmar B; Zechner D
    Cell Signal; 2018 Jul; 47():101-108. PubMed ID: 29609037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein.
    Song JG; Lee YS; Park JA; Lee EH; Lim SJ; Yang SJ; Zhao M; Lee K; Han HK
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):735-44. PubMed ID: 27520631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1.
    Kim BS; Lee K; Jung HJ; Bhattarai D; Kwon HJ
    Biochem Biophys Res Commun; 2015 Feb; 458(1):14-20. PubMed ID: 25603055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells.
    Mai L; Luo M; Wu JJ; Yang JH; Hong LY
    Neoplasma; 2019 Sep; 66(5):776-784. PubMed ID: 31169018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer.
    Nambara S; Masuda T; Nishio M; Kuramitsu S; Tobo T; Ogawa Y; Hu Q; Iguchi T; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Saeki H; Oki E; Maehara Y; Suzuki A; Mimori K
    Oncotarget; 2017 Dec; 8(64):107666-107677. PubMed ID: 29296196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin attenuates PD-L1 expression through activating Hippo signaling pathway in colorectal cancer cells.
    Zhang JJ; Zhang QS; Li ZQ; Zhou JW; Du J
    Am J Transl Res; 2019; 11(11):6965-6976. PubMed ID: 31814900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization.
    Bajracharya R; Lee SH; Song JG; Kim M; Lee K; Han HK
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31052438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.
    Eleftheriadis T; Pissas G; Mavropoulos A; Liakopoulos V; Stefanidis I
    Biomed Rep; 2017 Nov; 7(5):439-444. PubMed ID: 29181155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Anti-Diabetic Drug Metformin and Boswellic Acid Nanoparticles: A Novel Strategy for Pancreatic Cancer Therapy.
    Snima KS; Nair RS; Nair SV; Kamath CR; Lakshmanan VK
    J Biomed Nanotechnol; 2015 Jan; 11(1):93-104. PubMed ID: 26301303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.
    Lu R; Yang J; Wei R; Ke J; Tian Q; Yu F; Liu J; Zhang J; Hong T
    PLoS One; 2018; 13(6):e0198938. PubMed ID: 29897998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target.
    Yoo W; Lee J; Jun E; Noh KH; Lee S; Jung D; Jung KH; Kim JS; Park YY; Kim SC; Kim S
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31575084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1.
    Shan L; Li Y; Jiang H; Tao Y; Qian Z; Li L; Cai F; Ma L; Yu Y
    J Cancer; 2017; 8(19):4087-4097. PubMed ID: 29187885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
    Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
    Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer.
    Niu Q; Li X; Xia D; Jiang Y; Tian Z; Bian C; Zhang C; Liu P; Zhang F; Yang Y; Wang G
    Exp Ther Med; 2017 Sep; 14(3):2094-2100. PubMed ID: 28962129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.